Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center.

Purpose: The identification of mutations in melanoma enables targeted therapy and improves patient outcomes. Barriers to molecular testing affect the quality of care and therapeutic options.

Methods: This retrospective study mapped testing timelines in adult patients with melanoma at the Princess Margaret Cancer Centre to identify obstacles to timely reporting and its impact on the initiation of therapy.